Wedbush Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
13,495
-1,245
| -8% | -$30.4K | 0.01% | 794 |
|
|
2025
Q1 | $306K | Buy |
+14,740
| New | +$306K | 0.01% | 805 |
|
|
2022
Q2 | – | Sell |
-4,724
| Closed | -$217K | – | 1075 |
|
|
2022
Q1 | $217K | Buy |
4,724
+135
| +3% | +$6.2K | 0.01% | 949 |
|
|
2021
Q4 | $281K | Sell |
4,589
-2,508
| -35% | -$154K | 0.01% | 899 |
|
|
2021
Q3 | $530K | Buy |
7,097
+3,786
| +114% | +$283K | 0.03% | 586 |
|
|
2021
Q2 | $306K | Sell |
3,311
-25
| -0.7% | -$2.31K | 0.01% | 854 |
|
|
2021
Q1 | $296K | Buy |
+3,336
| New | +$296K | 0.02% | 819 |
|